Decreased apopto-phagocytic gene expression in the macrophages of systemic lupus erythematosus patients

Lupus

Volumn 23, Issue 2, 2014, Pages 133-145

  Majai, G ^a,b   Kiss, E ^b,c   Tarr, T ^b   Zahuczky, G ^a   Hartman, Z ^a   Szegedi, G ^b   Fesus L ^a  

^a UNIVERSITY OF DEBRECEN   (Hungary)

^b UNIVERSITY OF DEBRECEN   (Hungary)

^c NATIONAL INSTITUTE OF RHEUMATOLOGY AND PHYSIOTHERAPY   (Hungary)

Author keywords

apoptosis; autoimmunity; Lupus; macrophage; phagocytosis

Indexed keywords

ADORA2A PROTEIN; ADORA3 PROTEIN; ASGR1 PROTEIN; AUTOPHAGY PROTEIN 5; AXL PROTEIN; BECLIN 1; CAPN2 PROTEIN; CD31 ANTIGEN; CD68 ANTIGEN; DEOXYRIBONUCLEASE I; DEOXYRIBONUCLEASE II; DOCK1 PROTEIN; FOCAL ADHESION KINASE 1; FPR2 PROTEIN; GROWTH ARREST SPECIFIC PROTEIN 6; INTERCELLULAR ADHESION MOLECULE 3; INTERFERON REGULATORY FACTOR 4; INTERLEUKIN 10; INTERLEUKIN 12P40; INTERLEUKIN 23P19; INTERLEUKIN 6; JMJD6 PROTEIN; NEURONAL APOPTOSIS INHIBITORY PROTEIN; PROS1 PROTEIN; PROSTAGLANDIN E RECEPTOR 2; PROTEIN; PROTEIN GLUTAMINE GAMMA GLUTAMYLTRANSFERASE 2; THBS1 PROTEIN; TRANSFORMING GROWTH FACTOR BETA1; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG;

ADULT; APOPTOSIS; ARTICLE; AUTOIMMUNITY; AUTOPHAGY; CELL DIFFERENTIATION; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; FLOW CYTOMETRY; GENE EXPRESSION PROFILING; HUMAN; HUMAN CELL; HUMAN CELL CULTURE; INFLAMMATION; MACROPHAGE; MALE; MONOCYTE; NEUTROPHIL; PHAGOCYTOSIS; PRIORITY JOURNAL; SEROLOGY; SIGNAL TRANSDUCTION; SYSTEMIC LUPUS ERYTHEMATOSUS; UPREGULATION;

APOPTOSIS; AUTOIMMUNITY; LUPUS; MACROPHAGE; PHAGOCYTOSIS;

ADULT; ANTIGENS, SURFACE; APOPTOSIS; CASE-CONTROL STUDIES; CELL DIFFERENTIATION; DOWN-REGULATION; FEMALE; HUMANS; INTEGRIN BETA CHAINS; LUPUS ERYTHEMATOSUS, SYSTEMIC; MACROPHAGES; MALE; MIDDLE AGED; MILK PROTEINS; MONOCYTES; NEUTROPHILS; PHAGOCYTOSIS; RNA, MESSENGER; TRANSCRIPTOME; UP-REGULATION; YOUNG ADULT;

EID: 84892565880     PISSN: 09612033     EISSN: 14770962     Source Type: Journal    
DOI: 10.1177/0961203313511557     Document Type: Article

References (52)

1. Ravichandran KS. Beginnings of a good apoptotic meal: The find-me and eat-me signaling pathways. Immunity. 2011 ; 35: 445-555
2. Allen E, Farewell VT, Isenberg DA, Gordon C. A statistical analysis of the interrelationships between disease activity in different systems in systemic lupus erythematosus. Rheumatology (Oxford). 2006 ; 45: 308-313
3. Tarr T, Kiss E, Györi N. Analysis of different phenotypes in systemic lupus erythematosus. Magy Belorv Arch. 2011 ; 64: 93-98
4. Rodenburg RJ, Raats JM, Pruijn GJ, van Venrooij WJ. Cell death: A trigger of autoimmunity?. Bioessays. 2000 ; 22: 627-636
5. Rosen A, Casciola-Rosen L. Autoantigens as substrates for apoptotic proteases: Implications for the pathogenesis of systemic autoimmune disease. Cell Death Differ. 1999 ; 6: 6-12
6. Hakkim A, Furnrohr BG, Amann K, et al. Impairment of neutrophil extracellular trap degradation is associated with lupus nephritis. Proc Natl Acad Sci U S A. 2010 ; 107: 9813-9818
7. Nielsen CT, Ostergaard O, Stener L, et al. Increased IgG on cell-derived plasma microparticles in systemic lupus erythematosus is associated with autoantibodies and complement activation. Arthritis Rheum. 2012 ; 64: 1227-1236
8. Ardoin SP, Pisetsky DS. Developments in the scientific understanding of lupus. Arthritis Res Ther. 2008 ; 10: 218-218
9. Chitrabamrung S, Rubin RL, Tan EM. Serum deoxyribonuclease I and clinical activity in systemic lupus erythematosus. Rheumatol Int. 1981 ; 1: 55-60
10. Walport MJ, Davies KA, Botto M. C1q and systemic lupus erythematosus. Immunobiology. 1998 ; 199: 265-285
11. Botto M. Links between complement deficiency and apoptosis. Arthritis Res. 2001 ; 3: 207-210
12. Russell AI, Cunninghame Graham DS, Shepherd C, et al. Polymorphism at the C-reactive protein locus influences gene expression and predisposes to systemic lupus erythematosus. Hum Mol Genet. 2004 ; 13: 137-147
13. Suh CH, Hilliard B, Li S, Merrill JT, Cohen PL. TAM receptor ligands in lupus: Protein S but not Gas6 levels reflect disease activity in systemic lupus erythematosus. Arthritis Res Ther. 2010 ; 12: R146 - R146
14. Gaipl US, Munoz LE, Grossmayer G, et al. Clearance deficiency and systemic lupus erythematosus (SLE). J Autoimmun. 2007 ; 28: 114-121
15. Moosig F, Damm F, Knorr-Spahr A, et al. Reduced expression of C1q-mRNA in monocytes from patients with systemic lupus erythematosus. Clin Exp Immunol. 2006 ; 146: 409-416
16. Nakou M, Knowlton N, Frank MB, et al. Gene expression in systemic lupus erythematosus: Bone marrow analysis differentiates active from inactive disease and reveals apoptosis and granulopoiesis signatures. Arthritis Rheum. 2008 ; 58: 3541-3549
17. Richez C, Blanco P, Rifkin I, Moreau JF, Schaeverbeke T. Role for toll-like receptors in autoimmune disease: The example of systemic lupus erythematosus. Joint Bone Spine. 2010 ; 78: 124-130
18. Tan EM, Cohen AS, Fries JF, et al. The 1982 revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum. 1982 ; 25: 1271-1277
19. Majai G, Sarang Z, Csomos K, Zahuczky G, Fesus L. PPARgamma-dependent regulation of human macrophages in phagocytosis of apoptotic cells. Eur J Immunol. 2007 ; 37: 1343-1354
20. Yamaguchi H, Takagi J, Miyamae T, et al. Milk fat globule EGF factor 8 in the serum of human patients of systemic lupus erythematosus. J Leukoc Biol. 2008 ; 83: 1300-1307
21. Szondy Z, Sarang Z, Molnar P, et al. Transglutaminase 2-/- mice reveal a phagocytosis-associated crosstalk between macrophages and apoptotic cells. Proc Natl Acad Sci U S A. 2003 ; 100: 7812-7817
22. Kawane K, Ohtani M, Miwa K, et al. Chronic polyarthritis caused by mammalian DNA that escapes from degradation in macrophages. Nature. 2006 ; 443: 998-1002
23. Zhang Z, Kyttaris VC, Tsokos GC. The role of IL-23/IL-17 axis in lupus nephritis. J Immunol. 2009 ; 183: 3160-3169
24. Andrade F, Casciola-Rosen L, Rosen A. Apoptosis in systemic lupus erythematosus. Clinical implications. Rheum Dis Clin North Am. 2000 ; 26: 215-227, v
25. Casciola-Rosen LA, Anhalt G, Rosen A. Autoantigens targeted in systemic lupus erythematosus are clustered in two populations of surface structures on apoptotic keratinocytes. J Exp Med. 1994 ; 179: 1317-1330
26. Urbonaviciute V, Furnrohr BG, Meister S, et al. Induction of inflammatory and immune responses by HMGB1-nucleosome complexes: Implications for the pathogenesis of SLE. J Exp Med. 2008 ; 205: 3007-3018
27. Donnelly S, Roake W, Brown S, et al. Impaired recognition of apoptotic neutrophils by the C1q/calreticulin and CD91 pathway in systemic lupus erythematosus. Arthritis Rheum. 2006 ; 54: 1543-1556
28. Reefman E, Horst G, Nijk MT, Limburg PC, Kallenberg CG, Bijl M. Opsonization of late apoptotic cells by systemic lupus erythematosus autoantibodies inhibits their uptake via an Fcgamma receptor-dependent mechanism. Arthritis Rheum. 2007 ; 56: 3399-3411
29. Asano K, Miwa M, Miwa K, et al. Masking of phosphatidylserine inhibits apoptotic cell engulfment and induces autoantibody production in mice. J Exp Med. 2004 ; 200: 459-467
30. Silverman GJ. Rethinking the red wolf disease: Does Protein S suppress systemic lupus erythematosus clinical activity?. Arthritis Res Ther. 2010 ; 12: 144-144
31. Prasad D, Rothlin CV, Burrola P, et al. TAM receptor function in the retinal pigment epithelium. Mol Cell Neurosci. 2006 ; 33: 96-108
32. Xiong W, Chen Y, Wang H, Wu H, Lu Q, Han D. Gas6 and the Tyro 3 receptor tyrosine kinase subfamily regulate the phagocytic function of Sertoli cells. Reproduction. 2008 ; 135: 77-87
33. Rothlin CV, Ghosh S, Zuniga EI, Oldstone MB, Lemke G. TAM receptors are pleiotropic inhibitors of the innate immune response. Cell. 2007 ; 131: 1124-1136
34. Scott RS, McMahon EJ, Pop SM, et al. Phagocytosis and clearance of apoptotic cells is mediated by MER. Nature. 2001 ; 411: 207-211
35. Zhang Y, Liu S, Yu Y, et al. Immune complex enhances tolerogenecity of immature dendritic cells via FcgammaRIIb and promotes FcgammaRIIb-overexpressing dendritic cells to attenuate lupus. Eur J Immunol. 2011 ; 41: 1154-1164
36. Minakuchi R, Wacholtz MC, Davis LS, Lipsky PE. Delineation of the mechanism of inhibition of human T cell activation by PGE2. J Immunol. 1990 ; 145: 2616-2625
37. Ahmadi M, Emery DC, Morgan DJ. Prevention of both direct and cross-priming of antitumor CD8+ T-cell responses following overproduction of prostaglandin E2 by tumor cells in vivo. Cancer Res. 2008 ; 68: 7520-7529
38. Bryn T, Yaqub S, Mahic M, Henjum K, Aandahl EM, Tasken K. LPS-activated monocytes suppress T-cell immune responses and induce FOXP3+ T cells through a COX-2-PGE2-dependent mechanism. Int Immunol. 2008 ; 20: 235-245
39. Garrone P, Galibert L, Rousset F, Fu SM, Banchereau J. Regulatory effects of prostaglandin E2 on the growth and differentiation of human B lymphocytes activated through their CD40 antigen. J Immunol. 1994 ; 152: 4282-4290
40. Splawski JB, Lipsky PE. Prostaglandin E2 inhibits T cell-dependent Ig secretion by neonatal but not adult lymphocytes. J Immunol. 1994 ; 152: 5259-5267
41. Wild G, Watkins J, Ward AM, Hughes P, Hume A, Rowell NR. C4a anaphylatoxin levels as an indicator of disease activity in systemic lupus erythematosus. Clin Exp Immunol. 1990 ; 80: 167-170
42. Ma L, Mauro C, Cornish GH, et al. Ig gene-like molecule CD31 plays a nonredundant role in the regulation of T-cell immunity and tolerance. Proc Natl Acad Sci U S A. 2010 ; 107: 19461-19466
43. Bijl M, Horst G, Limburg PC, Kallenberg CG. Anti-CD3-induced and anti-Fas-induced apoptosis in systemic lupus erythematosus (SLE). Clin Exp Immunol. 2001 ; 123: 127-132
44. Koroskenyi K, Duro E, Pallai A, et al. Involvement of adenosine A2A receptors in engulfment-dependent apoptotic cell suppression of inflammation. J Immunol. 2011 ; 186: 7144-7155
45. Varani K, Massara A, Vincenzi F, et al. Normalization of A2A and A3 adenosine receptor up-regulation in rheumatoid arthritis patients by treatment with anti-tumor necrosis factor alpha but not methotrexate. Arthritis Rheum. 2009 ; 60: 2880-2891
46. Szabo C, Scott GS, Virag L, et al. Suppression of macrophage inflammatory protein (MIP)-1alpha production and collagen-induced arthritis by adenosine receptor agonists. Br J Pharmacol. 1998 ; 125: 379-387
47. Jeon JW, Jung JG, Shin EC, et al. Soluble CD93 induces differentiation of monocytes and enhances TLR responses. J Immunol. 2010 ; 185: 4921-4927
48. Levine B, Kroemer G. Autophagy in the pathogenesis of disease. Cell. 2008 ; 132: 27-42
49. Ogura Y, Bonen DK, Inohara N, et al. A frameshift mutation in NOD2 associated with susceptibility to Crohn's disease. Nature. 2001 ; 411: 603-606
50. Harley JB, Alarcon-Riquelme ME, Criswell LA, et al. Genome-wide association scan in women with systemic lupus erythematosus identifies susceptibility variants in ITGAM, PXK, KIAA1542 and other loci. Nat Genet. 2008 ; 40: 204-210
51. Gateva V, Sandling JK, Hom G, et al. A large-scale replication study identifies TNIP1, PRDM1, JAZF1, UHRF1BP1 and IL10 as risk loci for systemic lupus erythematosus. Nat Genet. 2009 ; 41: 1228-1233
52. Han JW, Zheng HF, Cui Y, et al. Genome-wide association study in a Chinese Han population identifies nine new susceptibility loci for systemic lupus erythematosus. Nat Genet. 2009 ; 41: 1234-1237